Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

QDEL

QuidelOrtho Corporation

Feb 13 • 04:00PM ET

23.58

-0.16 -0.65 %

Healthcare • Medical Devices • USA • NASD

Feb 12, 8:30 PMDisappointing FY2026 EPS guidance sparked 17.59% intraday plunge despite Q4 earnings beat.

Peers: ABT TMO BDX BIO HOLX DGX LH ALC COO RMD

| Held by: IJR VTI AVUV VB IWM VBR VXF IJS SPSM VTWO

Index	RUT	P/E	-	EPS (ttm)	-16.66	Insider Own	1.07%	Shs Outstand	67.93M	Perf Week	-18.97%
Market Cap	1.60B	Forward P/E	7.99	EPS next Y	2.95	Insider Trans	7.43%	Shs Float	67.20M	Perf Month	-31.33%
Enterprise Value	4.24B	PEG	0.45	EPS next Q	0.50	Inst Own	120.12%	Short Float	15.43%	Perf Quarter	4.38%
Income	-1.13B	P/S	0.59	EPS this Y	3.10%	Inst Trans	3.73%	Short Ratio	9.82	Perf Half Y	-9.13%
Sales	2.73B	P/B	0.79	EPS next Y	34.95%	ROA	-17.77%	Short Interest	10.37M	Perf YTD	-17.44%
Book/sh	29.99	P/C	9.43	EPS next 5Y	17.83%	ROE	-46.15%	52W High	43.92 -46.31%	Perf Year	-43.39%
Cash/sh	2.50	P/FCF	-	EPS past 3/5Y	- -	ROIC	-24.89%	52W Low	19.50 20.92%	Perf 3Y	-72.65%
Dividend Est.	-	EV/EBITDA	8.46	Sales past 3/5Y	-5.77% 10.44%	Gross Margin	39.85%	Volatility	10.38% 7.57%	Perf 5Y	-89.66%
Dividend TTM	-	EV/Sales	1.55	EPS Y/Y TTM	44.97%	Oper. Margin	2.16%	ATR (14)	2.06	Perf 10Y	57.30%
Dividend Ex-Date	-	Quick Ratio	0.90	Sales Y/Y TTM	-1.73%	Profit Margin	-41.41%	RSI (14)	30.36	Recom	2.67
Dividend Gr. 3/5Y	- -	Current Ratio	1.50	EPS Q/Q	15.68%	SMA20	-17.07%	Beta	0.74	Target Price	33.71
Payout	-	Debt/Eq	1.46	Sales Q/Q	2.17%	SMA50	-19.81%	Rel Volume	2.37	Prev Close	23.74
Employees	6600	LT Debt/Eq	1.37	Earnings	Feb 11 AMC	SMA200	-16.61%	Avg Volume	1.06M	Price	23.58
IPO	Feb 01, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.08% 3.26%	Trades		Volume	2,504,999	Change	-0.65%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-07-25	Downgrade	Citigroup	Buy → Neutral	$33
May-08-25	Upgrade	Jefferies	Hold → Buy	$44
Dec-11-24	Upgrade	Citigroup	Neutral → Buy	$44 → $50
Dec-10-24	Initiated	Jefferies	Hold	$43
Sep-19-24	Resumed	UBS	Neutral	$42 → $50
Sep-05-24	Upgrade	Craig Hallum	Hold → Buy	$40 → $57
Mar-04-24	Downgrade	UBS	Neutral → Sell	$70 → $42
Feb-14-24	Downgrade	JP Morgan	Neutral → Underweight	$66 → $37
Dec-11-23	Downgrade	Citigroup	Buy → Neutral	$95 → $72
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$90 → $125
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$125
Oct-14-22	Upgrade	UBS	Sell → Neutral	$86
Sep-19-22	Initiated	Citigroup	Neutral	$90
Jul-20-22	Initiated	UBS	Sell	$86
Jun-17-22	Resumed	JP Morgan	Neutral	$80 → $110
Feb-22-22	Upgrade	Raymond James	Outperform → Strong Buy	$155 → $130
Jan-22-21	Upgrade	Raymond James	Mkt Perform → Outperform	$250
May-12-20	Downgrade	JP Morgan	Neutral → Underweight	$120 → $158
Mar-26-20	Downgrade	Barclays	Overweight → Equal Weight	$90
Oct-23-18	Resumed	Raymond James	Strong Buy	$80

Show Previous Ratings

Feb-12-26 09:45AM	QDEL Q4 Deep Dive: Margin Expansion, R&D Pipeline, and Guidance Disappoints (StockStory) -17.59%
09:25AM	QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down (Zacks)
08:30AM	QuidelOrtho Corporation Q4 2025 Earnings Call Summary (Moby)
12:00AM	QuidelOrtho Corp (QDEL) Q4 2025 Earnings Call Highlights: Strong Labs Growth Amidst Respiratory ... (GuruFocus.com)
Feb-11-26 06:39PM	QuidelOrtho Q4 Earnings Call Highlights (MarketBeat)
05:25PM	Loading…
05:25PM	QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates (Zacks)
04:56PM	QuidelOrtho (NASDAQ:QDEL) Exceeds Q4 CY2025 Expectations (StockStory)
04:27PM	QuidelOrtho: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results (PR Newswire)
Feb-09-26 10:04PM	Earnings To Watch: QuidelOrtho (QDEL) Reports Q4 Results Tomorrow (StockStory)
Feb-04-26 10:00AM	Earnings Preview: QuidelOrtho (QDEL) Q4 Earnings Expected to Decline (Zacks)
Feb-03-26 07:12AM	QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie Awards (PR Newswire)
Jan-28-26 11:02PM	3 Reasons to Sell QDEL and 1 Stock to Buy Instead (StockStory)
Jan-27-26 11:04PM	3 Reasons QDEL is Risky and 1 Stock to Buy Instead (StockStory)
Jan-22-26 07:12AM	Strengthening the blood supply: Awareness, challenges and donor impact (PR Newswire)
07:00AM	Loading…
Jan-21-26 07:00AM	QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results (PR Newswire) -10.11%
Jan-15-26 10:37AM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks)
Dec-18-25 09:17AM	Innovating Diagnostics and What's Next (PR Newswire)
Dec-11-25 10:32PM	QuidelOrtho (NASDAQ:QDEL) Q3 Earnings: Leading The Medical Devices & Supplies - Imaging, Diagnostics Pack (StockStory)
Dec-03-25 11:45AM	Why QuidelOrtho (QDEL) Stock Is Up Today (StockStory)
Nov-25-25 01:00PM	QuidelOrtho (QDEL) Stock Trades Up, Here Is Why (StockStory) +5.85%
Nov-24-25 07:00AM	QuidelOrtho To Participate In Upcoming Investor Conferences (PR Newswire) +9.16%
Nov-21-25 05:15PM	QuidelOrtho (QDEL) Shares Skyrocket, What You Need To Know (StockStory) +14.27%
Nov-20-25 09:00AM	The Power of Prevention: Detecting Diabetes Before It Strikes (PR Newswire)
Nov-12-25 12:35AM	5 Revealing Analyst Questions From QuidelOrtho's Q3 Earnings Call (StockStory)
Nov-06-25 01:25PM	QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand (Zacks) -22.32%
11:37AM	Why QuidelOrtho (QDEL) Stock Is Down Today (StockStory)
09:16AM	QDEL Q3 Deep Dive: Margin Progress and Cost Actions Offset Headwinds in Core Diagnostics (StockStory)
12:12AM	QuidelOrtho Corp (QDEL) Q3 2025 Earnings Call Highlights: Navigating Revenue Declines with ... (GuruFocus.com)
Nov-05-25 04:54PM	QuidelOrtho: Q3 Earnings Snapshot (Associated Press Finance)
04:52PM	Loading…
04:52PM	QuidelOrtho (NASDAQ:QDEL) Beats Q3 Sales Expectations (StockStory)
04:05PM	QuidelOrtho Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-03-25 10:04PM	QuidelOrtho (QDEL) Q3 Earnings: What To Expect (StockStory)
07:00AM	QuidelOrtho Receives FDA 510(k) Clearance for VITROS Immunodiagnostic Products hs Troponin I Assay (PR Newswire)
Oct-30-25 08:25AM	Baxter International (BAX) Beats Q3 Earnings Estimates (Zacks)
Oct-29-25 07:30AM	GE HealthCare Technologies (GEHC) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Oct-23-25 06:45PM	Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics (PR Newswire)
12:44AM	1 Small-Cap Stock with Exciting Potential and 2 We Avoid (StockStory)
Oct-22-25 07:00AM	QuidelOrtho to Report Third Quarter 2025 Financial Results (PR Newswire)
Oct-20-25 01:36PM	Why QuidelOrtho (QDEL) Stock Is Up Today (StockStory)
Oct-16-25 08:30PM	QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025 (PR Newswire)
Oct-07-25 11:30AM	Why QuidelOrtho (QDEL) Stock Is Down Today (StockStory) -6.40%
Sep-30-25 09:30AM	QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test (Zacks)
Sep-26-25 09:53AM	QuidelOrtho Corp. (QDEL) Traded Lower Due to Macro Concerns (Insider Monkey) +6.76%
Sep-25-25 09:00AM	Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters (PR Newswire)
Sep-23-25 11:31PM	Q2 Rundown: QuidelOrtho (NASDAQ:QDEL) Vs Other Medical Devices & Supplies - Imaging, Diagnostics Stocks (StockStory)
Sep-22-25 07:00AM	QuidelOrtho Announces Availability of QUICKVUE Influenza + SARS Test for Professional Use (PR Newswire)
Sep-18-25 11:30AM	Medtronic (MDT) Up 1.5% Since Last Earnings Report: Can It Continue? (Zacks)
Sep-10-25 12:20AM	RBC Capital Raises PT on QuidelOrtho Corporation From $60 to $62, Keeps Buy Rating (Insider Monkey)
Aug-28-25 07:30AM	QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference (PR Newswire)
Aug-21-25 04:30PM	QuidelOrtho Completes Debt Refinancing (PR Newswire) +8.73%
09:00AM	Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities (PR Newswire)
Aug-19-25 04:05PM	QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development (PR Newswire)
Aug-18-25 12:02AM	QuidelOrtho (QDEL): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Aug-14-25 11:13AM	QuidelOrtho launches certified analyser programme for rural health facilities (Hospital Management)
Aug-13-25 03:00PM	QuidelOrtho Launches Certified Analyzer Program (PR Newswire) +7.50%
12:10AM	QDEL Q2 Deep Dive: Cost Controls and International Growth Offset Lower COVID Diagnostics (StockStory)
Aug-12-25 11:59PM	The Top 5 Analyst Questions From QuidelOrtho's Q2 Earnings Call (StockStory) +6.56%
Aug-08-25 09:45AM	Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term (Zacks)
Aug-07-25 09:40AM	Should Value Investors Buy QuidelOrtho (QDEL) Stock? (Zacks)
Aug-06-25 01:02PM	QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand (Zacks)
03:36AM	QuidelOrtho Corp (QDEL) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... (GuruFocus.com)
Aug-05-25 05:57PM	QuidelOrtho's (NASDAQ:QDEL) Q2 Earnings Results: Revenue In Line With Expectations, Stock Soars (StockStory)
05:14PM	QuidelOrtho: Q2 Earnings Snapshot (Associated Press Finance)
04:10PM	QuidelOrtho Reports Second Quarter 2025 Financial Results (PR Newswire)
Aug-04-25 01:32PM	QuidelOrtho Corporation (QDEL): A Bull Case Theory (Insider Monkey) +5.70%
Aug-03-25 11:12PM	QuidelOrtho (QDEL) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-29-25 05:00PM	QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak (PR Newswire)
Jul-28-25 12:01PM	Why QuidelOrtho (QDEL) Shares Are Sliding Today (StockStory)
Jul-24-25 09:00AM	Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast (PR Newswire)
Jul-22-25 04:30PM	QuidelOrtho to Report Second Quarter 2025 Financial Results (PR Newswire)
Jul-18-25 03:10PM	QuidelOrtho, Acadia Healthcare, Elevance Health, Molina Healthcare, and Alignment Healthcare Stocks Trade Down, What You Need To Know (StockStory)
Jul-17-25 07:00AM	Real Labs, Actual Decisions With Actionable Six Sigma Metrics (PR Newswire)
Jul-16-25 09:39AM	RBC Capital Maintains a Buy Rating on QuidelOrtho Corporation (QDEL), Sets a $60 PT (Insider Monkey)
Jul-14-25 07:00AM	QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS SYSTEMS AS A MICROTIP PARTNERSHIP ASSAY (MPA) (PR Newswire)
07:00AM	QUIDELORTHO AND BUHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL) TURBO AND FECAL PANCREATIC ELASTASE (FPELA) TURBO ASSAYS ON VITROS SYSTEMS AS A MICROTIP PARTNERSHIP ASSAY (MPA) (PR Newswire)
Jul-09-25 11:38PM	A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks' Q1 Earnings: QuidelOrtho (NASDAQ:QDEL) Vs The Rest Of The Pack (StockStory)
Jul-08-25 07:42AM	Best Value Stocks to Buy for July 8th (Zacks) +5.48%
Jul-07-25 10:21AM	5 Revealing Analyst Questions From QuidelOrtho's Q1 Earnings Call (StockStory)
07:00AM	QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs (PR Newswire)
Jul-04-25 09:45AM	Here's Why QuidelOrtho (QDEL) is a Strong Growth Stock (Zacks)
09:40AM	Are Investors Undervaluing QuidelOrtho (QDEL) Right Now? (Zacks)
Jun-24-25 10:43AM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks)
Jun-18-25 12:00PM	What Makes QuidelOrtho (QDEL) a New Buy Stock (Zacks)
09:45AM	Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term (Zacks)
09:40AM	Should Value Investors Buy QuidelOrtho (QDEL) Stock? (Zacks)
Jun-16-25 12:01AM	3 Reasons to Sell QDEL and 1 Stock to Buy Instead (StockStory)
Jun-11-25 06:56AM	QDEL Q1 Earnings Call: Cost Savings and Tariff Mitigation Anchor 2025 Outlook (StockStory)
12:32AM	1 Stock Under $50 Worth Your Attention and 2 to Approach with Caution (StockStory)
Jun-06-25 11:31AM	QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound? (Zacks)
Jun-03-25 04:10PM	QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics (PR Newswire)
09:50AM	Why QuidelOrtho (QDEL) is a Top Momentum Stock for the Long-Term (Zacks)
Jun-02-25 09:45AM	Here's Why QuidelOrtho (QDEL) is a Strong Growth Stock (Zacks)
May-22-25 04:30PM	QuidelOrtho to Participate in Upcoming Investor Conferences (Business Wire)
May-21-25 09:44AM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks) -8.65%
May-16-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
May-15-25 09:45AM	Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term (Zacks)
May-09-25 12:01PM	Trump announces trade deal, BoE lowers Bank Rate: Morning Buzz (TipRanks)
12:41AM	Why QuidelOrtho Corporation (QDEL) Went Up On Thursday (Insider Monkey)
May-08-25 12:10PM	QuidelOrtho Stock Gains Following Q1 Earnings Beat, Margins Expand (Zacks) +41.04%

QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Strobeck Matthew	Director	Feb 13 '26	Buy	23.96	10,000	239,586	27,775	Feb 13 04:20 PM
Busky Joseph M.	Chief Financial Officer	Feb 13 '26	Buy	23.66	3,370	79,742	10,290	Feb 13 12:44 PM
Blaser Brian J.	President and CEO	Feb 13 '26	Buy	23.59	10,540	248,661	40,073	Feb 13 10:43 AM
RHOADS ANN D	Director	Dec 10 '25	Buy	28.27	750	21,206	15,021	Dec 10 06:37 PM
Wilkins Joseph D Jr.	Director	Nov 26 '25	Buy	27.95	370	10,343	11,876	Dec 01 04:33 PM
WIDDER KENNETH J	Director	Nov 25 '25	Option Exercise	15.74	7,021	110,511	41,087	Nov 25 04:16 PM
WIDDER KENNETH J	Director	Nov 25 '25	Sale	27.81	4,026	111,965	37,061	Nov 25 04:16 PM
KENNETH WIDDER	Director	Nov 25 '25	Proposed Sale	27.81	4,026	111,965		Nov 25 04:11 PM
Busky Joseph M.	Chief Financial Officer	Nov 24 '25	Buy	26.06	4,770	124,305	6,920	Nov 25 01:21 PM
POLAN MARY LAKE PH D	Director	Nov 21 '25	Buy	22.43	1,000	22,430	12,640	Nov 24 04:09 PM
Blaser Brian J.	President and CEO	Nov 19 '25	Buy	21.34	23,500	501,577	29,533	Nov 20 04:16 PM
BUECHLER KENNETH F	Director	Jul 15 '25	Option Exercise	15.74	9,215	145,044	101,921	Jul 17 04:09 PM

Open in Screener

BDSX

Biodesix Inc

Feb 13 • 04:00PM ET

11.45

+0.61 5.68 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN BEAM CDNA FLGT GH EXAS QDEL TWST CRSP PACB

| Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-5.37	Insider Own	60.69%	Shs Outstand	7.95M	Perf Week	10.31%
Market Cap	91.09M	Forward P/E	-	EPS next Y	-2.58	Insider Trans	377.61%	Shs Float	3.13M	Perf Month	33.29%
Enterprise Value	147.32M	PEG	-	EPS next Q	-0.86	Inst Own	21.48%	Short Float	7.97%	Perf Quarter	44.03%
Income	-39.54M	P/S	1.14	EPS this Y	22.00%	Inst Trans	-3.50%	Short Ratio	0.18	Perf Half Y	44.21%
Sales	80.17M	P/B	-	EPS next Y	49.97%	ROA	-41.30%	Short Interest	0.25M	Perf YTD	68.38%
Book/sh	-0.22	P/C	5.45	EPS next 5Y	44.09%	ROE	-302.55%	52W High	20.40 -43.87%	Perf Year	-40.55%
Cash/sh	2.10	P/FCF	-	EPS past 3/5Y	40.57% 69.26%	ROIC	-56.64%	52W Low	3.44 233.24%	Perf 3Y	-69.05%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.38% 23.77%	Gross Margin	79.82%	Volatility	13.30% 15.35%	Perf 5Y	-97.69%
Dividend TTM	-	EV/Sales	1.84	EPS Y/Y TTM	31.93%	Oper. Margin	-40.35%	ATR (14)	1.34	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.76	Sales Y/Y TTM	22.29%	Profit Margin	-49.31%	RSI (14)	61.65	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	1.84	EPS Q/Q	17.13%	SMA20	10.73%	Beta	0.65	Target Price	32.50
Payout	-	Debt/Eq	-	Sales Q/Q	19.93%	SMA50	34.32%	Rel Volume	0.24	Prev Close	10.84
Employees	273	LT Debt/Eq	-	Earnings	Feb 26 AMC	SMA200	50.87%	Avg Volume	1.41M	Price	11.45
IPO	Oct 28, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	22.15% 3.79%	Trades		Volume	331,766	Change	5.68%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-25	Downgrade	William Blair	Outperform → Mkt Perform
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy	$3
May-13-24	Initiated	TD Cowen	Buy	$2.80
May-03-24	Initiated	Lake Street	Buy	$3
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$21 → $11
Nov-23-20	Initiated	William Blair	Outperform
Nov-23-20	Initiated	Morgan Stanley	Overweight	$20
Nov-23-20	Initiated	Canaccord Genuity	Buy	$26
Nov-23-20	Initiated	BTIG Research	Buy	$22

Feb-12-26 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (GlobeNewswire)
Jan-31-26 08:15AM	Insiders Are Still Scooping Up Under Armour and WR Berkley Shares (24/7 Wall St.)
Jan-12-26 06:00AM	Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited) (GlobeNewswire) +47.99%
Dec-24-25 01:48PM	SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio (Zacks)
Dec-19-25 11:05AM	Cencora to Acquire OneOncology to Expand Community Oncology Solutions (Zacks) -5.77%
09:55AM	Loading…
Dec-03-25 09:55AM	Wall Street Analysts Believe Biodesix (BDSX) Could Rally 325.67%: Here's is How to Trade (Zacks)
08:22AM	Biodesix to Present New Data at Two Major Upcoming Scientific Meetings (GlobeNewswire)
Nov-04-25 12:01AM	Biodesix Inc (BDSX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Costs (GuruFocus.com) +19.87%
Nov-03-25 05:30PM	Biodesix, Inc. (BDSX) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.17%
04:01PM	Biodesix Announces Third Quarter 2025 Results and Highlights (GlobeNewswire)
Oct-31-25 09:35AM	What To Expect From Biodesix Inc (BDSX) Q3 2025 Earnings (GuruFocus.com)
Oct-30-25 06:17AM	Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting (GlobeNewswire)
Oct-29-25 05:45PM	Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Oct-27-25 07:10AM	Revvity (RVTY) Surpasses Q3 Earnings Estimates (Zacks)
Oct-22-25 06:17AM	Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital PCR High Complexity Assays (GlobeNewswire) -12.15%
06:00AM	Loading…
Oct-20-25 06:00AM	Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025 (GlobeNewswire)
Oct-15-25 06:09AM	Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting (GlobeNewswire)
Oct-06-25 10:13AM	Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit (GlobeNewswire)
Sep-11-25 08:00AM	Biodesix Announces One-for-Twenty Reverse Stock Split (GlobeNewswire) -20.82%
Sep-05-25 06:00AM	Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference (GlobeNewswire)
Sep-04-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +5.05%
Aug-19-25 09:47AM	Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics (GlobeNewswire)
Aug-07-25 05:20PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +14.62% -10.40%
04:06PM	Biodesix Announces Second Quarter 2025 Results and Highlights (GlobeNewswire)
Aug-05-25 06:00AM	Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire) +10.10%
Aug-01-25 07:15AM	Avantor, Inc. (AVTR) Q2 Earnings Lag Estimates (Zacks)
Jul-25-25 12:22PM	Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers (Insider Monkey) +6.80%
12:22PM	Sangamo Therapeutics Announces Positive Phase 1/2 STAAR Study Results for Fabry Gene Therapy (Insider Monkey)
Jul-24-25 06:00AM	Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jun-10-25 06:17AM	Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs (GlobeNewswire) +13.91%
05:03PM	Loading…
May-22-25 05:03PM	Biodesix Announces New Data on the VeriStrat Test to be Presented at the 2025 ASCO Annual Meeting (GlobeNewswire) -9.92%
May-21-25 06:00AM	Biodesix to Participate in Upcoming Investor Conferences (GlobeNewswire) +45.90%
May-15-25 06:00AM	Biodesix Announces New Clinical and Economic Data for its Nodify Lung Tests at ISPOR and ATS (GlobeNewswire)
May-14-25 04:01PM	Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award (GlobeNewswire) -38.74%
03:16AM	Biodesix Inc (BDSX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Sales Team ... (GuruFocus.com)
May-13-25 05:15PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2025 Results and Highlights (GlobeNewswire)
May-12-25 09:50AM	Biodesix Inc (BDSX) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
09:25AM	Sonida Senior Living (SNDA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-08-25 06:30PM	DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -17.91% +6.84%
Apr-30-25 07:45AM	GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates (Zacks)
Apr-29-25 06:00AM	Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire) -6.51%
Apr-28-25 07:15AM	Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates (Zacks) +6.25%
Apr-25-25 07:15AM	Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates (Zacks) -5.64%
Apr-23-25 06:00AM	Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types (GlobeNewswire)
Mar-06-25 12:00PM	Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-04-25 05:20AM	Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025 (Insider Monkey)
02:03AM	Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Mar-03-25 04:01PM	Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results (GlobeNewswire) -10.09%
Feb-28-25 07:15AM	Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-26-25 06:00AM	Biodesix to Present at TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-18-25 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 (GlobeNewswire)
Jan-10-25 06:00AM	Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) (GlobeNewswire) -14.19%
Jan-07-25 06:00AM	Biodesix Announces Publication of a New Nodify CDT Clinical Validation Study (GlobeNewswire)
Nov-20-24 09:35AM	Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-02-24 03:01AM	Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... (GuruFocus.com)
Nov-01-24 07:15AM	Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -23.53%
06:00AM	Biodesix Announces Third Quarter 2024 Results and Highlights (GlobeNewswire)
Oct-31-24 09:06AM	What To Expect From Biodesix Inc (BDSX) Q3 2024 Earnings (GuruFocus.com)
Oct-29-24 06:00AM	Biodesix to Participate in Three Investor Conferences in November (GlobeNewswire)
Oct-18-24 06:00AM	Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 (Business Wire)
Oct-07-24 06:00AM	Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study (Business Wire)
Sep-05-24 06:00AM	Biodesix to Present at Two Investor Conferences in September (Business Wire)
Aug-08-24 10:23AM	Q2 2024 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-24 06:05PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces Second Quarter 2024 Results and Highlights (Business Wire)
Aug-06-24 06:00AM	Biodesix to Present at Canaccord Genuitys 44th Annual Growth Conference (Business Wire)
Jul-24-24 06:00AM	Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire)
Jun-18-24 08:13AM	Biodesix Named to Inc. Magazine's 2024 "Best Workplaces" (Business Wire)
May-28-24 06:00AM	Biodesix to Participate in Two Investor Conferences in June (Business Wire)
May-21-24 06:00AM	Biodesix to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting (Business Wire)
May-10-24 05:59PM	Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:55PM	Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance (GuruFocus.com)
May-09-24 03:46AM	Biodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-08-24 09:00PM	BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:20PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management (Business Wire)
May-07-24 06:00AM	Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference (Business Wire)
Apr-24-24 06:00AM	Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 (Business Wire)
Apr-09-24 05:00PM	Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting (Business Wire) -9.93%
Apr-05-24 07:17AM	Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement (Business Wire) -7.28%
Mar-25-24 06:00AM	Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center (Business Wire)
Mar-04-24 09:04AM	Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 10:40PM	Q4 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
06:31AM	Biodesix Inc (BDSX) Reports Strong Growth in Lung Diagnostic Test Volume and Gross Profit Margin (GuruFocus.com)
06:00AM	Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights (Business Wire)
Feb-26-24 06:00AM	Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference (Business Wire)
Feb-16-24 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 (Business Wire) -5.73%
Feb-13-24 03:00AM	Biodesix Inc CEO Scott Hutton Sells 64,390 Shares (GuruFocus.com)
Jan-26-24 09:04AM	3 Penny Stocks to Turn $999 Into $1 Million: January 2024 (InvestorPlace)
Nov-14-23 06:00AM	Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method (Business Wire)
Nov-09-23 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in November (Business Wire) -6.39%
Nov-07-23 04:01PM	Biodesix Announces Third Quarter 2023 Results and Highlights (Business Wire) -10.14%
Oct-24-23 06:00AM	Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023 (Business Wire) -5.00%
Oct-03-23 06:00AM	Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting (Business Wire)
Sep-07-23 06:00AM	Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer (Business Wire)
Sep-05-23 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in September (Business Wire) -11.76%
Aug-22-23 06:00AM	Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer (Business Wire)
Aug-09-23 10:25AM	Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript (Insider Monkey) -15.62%
Aug-08-23 08:38AM	Q2 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
O'Kane Kieran	Chief Commercial Officer	Feb 10 '26	Sale	10.08	584	5,889	8,885	Feb 11 06:03 PM
Vazquez Chris	Chief Accounting Officer	Feb 10 '26	Sale	10.08	101	1,018	1,234	Feb 11 06:03 PM
Hutton Scott	President & CEO	Feb 10 '26	Sale	10.08	3,559	35,889	45,413	Feb 11 06:03 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Feb 10 '26	Sale	10.08	941	9,489	15,297	Feb 11 06:03 PM
Pestano Gary Anthony	Chief Development Officer	Feb 10 '26	Sale	10.08	540	5,445	9,387	Feb 11 06:03 PM
SCHULER JACK W	Emeritus Director	Jan 23 '26	Buy	11.81	80,000	944,672	1,543,210	Jan 27 09:29 AM
SCHULER JACK W	Emeritus Director	Jan 26 '26	Buy	11.80	20,000	236,064	1,563,210	Jan 27 09:29 AM
SCHULER JACK W	Emeritus Director	Jan 22 '26	Buy	10.96	82,465	903,561	1,463,210	Jan 26 09:28 AM
Vazquez Chris	Chief Accounting Officer	Jan 16 '26	Sale	8.15	83	676	1,072	Jan 20 04:22 PM
Pestano Gary Anthony	Chief Development Officer	Jan 16 '26	Sale	8.15	298	2,428	8,446	Jan 20 04:21 PM
O'Kane Kieran	Chief Commercial Officer	Jan 16 '26	Sale	8.15	298	2,428	7,869	Jan 20 04:21 PM
Hutton Scott	President & CEO	Jan 16 '26	Sale	8.15	970	7,905	38,974	Jan 20 04:21 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Jan 16 '26	Sale	8.15	298	2,428	13,654	Jan 20 04:21 PM
Vazquez Chris	Chief Accounting Officer	Nov 10 '25	Sale	7.62	13	99	936	Nov 13 04:54 PM
Pestano Gary Anthony	Chief Development Officer	Nov 10 '25	Sale	7.62	23	175	7,939	Nov 13 04:54 PM
O'Kane Kieran	Chief Commercial Officer	Nov 10 '25	Sale	7.62	25	190	7,362	Nov 13 04:53 PM
Hutton Scott	President & CEO	Nov 10 '25	Sale	7.62	189	1,440	37,311	Nov 13 04:53 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Nov 10 '25	Sale	7.62	50	381	13,147	Nov 13 04:53 PM
SCHULER JACK W	Director	Sep 19 '25	Buy	7.04	142,045	999,997	1,380,745	Sep 23 09:29 AM
SCHULER JACK W	Director	Sep 17 '25	Buy	6.04	15,317	92,571	1,235,644	Sep 19 10:31 AM
SCHULER JACK W	Director	Sep 18 '25	Buy	6.17	3,056	18,854	1,238,700	Sep 19 10:31 AM
SCHULER JACK W	Director	Aug 29 '25	Buy	0.43	3,488,372	1,500,000	24,406,546	Sep 03 04:42 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Aug 13 '25	Sale	0.42	988	411	250,794	Aug 14 05:25 PM
Hutton Scott	President & CEO	Aug 13 '25	Sale	0.42	3,772	1,570	728,824	Aug 14 05:25 PM
O'Kane Kieran	Chief Commercial Officer	Aug 13 '25	Sale	0.42	476	198	140,065	Aug 14 05:24 PM
Pestano Gary Anthony	Chief Development Officer	Aug 13 '25	Sale	0.42	442	184	157,878	Aug 14 05:24 PM
Vazquez Chris	Chief Accounting Officer	Aug 13 '25	Sale	0.42	228	95	18,375	Aug 14 05:24 PM
SCHULER JACK W	Director	May 16 '25	Buy	0.27	4,000,000	1,070,000	20,194,935	May 20 04:11 PM
SCHULER JACK W	Director	May 19 '25	Buy	0.34	723,239	246,624	20,918,174	May 20 04:11 PM
Vazquez Chris	Chief Accounting Officer	May 12 '25	Sale	0.36	112	40	18,113	May 13 06:36 PM
Vazquez Chris	Chief Accounting Officer	May 13 '25	Sale	0.35	112	40	18,001	May 13 06:36 PM
Pestano Gary Anthony	Chief Development Officer	May 12 '25	Sale	0.36	223	80	157,163	May 13 06:36 PM
Pestano Gary Anthony	Chief Development Officer	May 13 '25	Sale	0.35	222	78	156,941	May 13 06:36 PM
O'Kane Kieran	Chief Commercial Officer	May 12 '25	Sale	0.36	239	86	139,290	May 13 06:35 PM
O'Kane Kieran	Chief Commercial Officer	May 13 '25	Sale	0.35	238	84	139,052	May 13 06:35 PM
Hutton Scott	President & CEO	May 12 '25	Sale	0.36	1,888	679	722,271	May 13 06:35 PM
Hutton Scott	President & CEO	May 13 '25	Sale	0.35	1,887	666	720,384	May 13 06:35 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	May 12 '25	Sale	0.36	496	178	249,121	May 13 06:35 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	May 13 '25	Sale	0.35	496	175	248,625	May 13 06:35 PM

QDEL

QuidelOrtho Corporation

BDSX

Biodesix Inc

Upgrade your FINVIZ experience